Hansen Medical, an innovator of intravascular robotics, recently declared that it has received 30 additional U.S. patents since January 2011, thereby augmenting its intellectual property range in medical robotics. In addition, Hansen Medical shares rights to over 250 issued U.S. patents associated with medical robotics via licensing arrangement with third parties.
Additional coverage for Hansen Medical's Magellan Robotic System has been granted by some of the patents. The novel robotic system has been designed to be used in the treatment of various peripheral vascular diseases. At present, it is being commercialized in the EU and the U.S.
In addition, most of the patents offer additional coverage for Hansen Medical's Sensei X Robotic Catheter System that fosters novel solutions for potential improvement to robotic technologies.
According to Hansen Medical President and CEO, Bruce J Barclay, the existing industry relies on patent protection. The intellectual property assets are vital for Hansen Medical as they ensure the distribution of products for use in several platforms beyond the firm’s core markets. Hansen Medical strives to strengthen patent protection covering the revolutionary work carried out by its expertise scientists and engineers.
Hansen Medical received 30 additional U.S. Patents for Surgical Instrument Coupling Mechanism, Flexible Instrument, Robotic Catheter System, Interchangeable Surgical Instrument, Apparatus Systems and Methods for Flushing Gas from a Catheter of a Robotic Catheter System, System and Method for 3-D Imaging, to name a few.
Source: http://www.hansenmedical.com/